23
total announcements
524723.BO · 15 min delayed
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd received in-principal approval from BSE for issuing 38,71,854 equity shares on a preferential basis at Rs. 40 per share.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended 30th September 2026.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has closed its trading window for the approval of unaudited financial statements for the second quarter and half year ended September 30, 2026, as per SEBI regulations.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has announced the results of its 41st Annual General Meeting (AGM), where all resolutions were approved by shareholders with requisite majority. The company provided remote e-voting facility and e-voting at the AGM, and the Scrutinizer's Report dated 22nd September 2026 is attached.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd held its 41st Annual General Meeting (AGM) on September 21, 2026, through video conferencing. The meeting approved the audited financial statements for FY 2025-26, re-appointed Kaushal Shah as Managing Director, and approved a material related party transaction for the acquisition of DEFIB Institute of Health Solutions LLP's copyright and intellectual property portfolio.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has informed the exchange about the incorporation of its wholly-owned subsidiary, Arvaya Insurance Broking Private Limited, under the Companies Act, 2013. The subsidiary received its Certificate of Incorporation from the Ministry of Corporate Affairs on September 17, 2026. The company has made the disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, within the prescribed timeline, albeit with a delay due to internal compilation and verification.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has published a newspaper advertisement regarding the dispatch of the 41st Annual General Meeting (AGM) notice, to be held on September 21, 2026, through video conferencing.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd announced the web link for its 41st Annual General Meeting (AGM) to be held on 21st September 2026. The meeting will be held through video conference facility/other audio visual means. The company has sent separate web links for accessing the Notice of the AGM and Annual Report to shareholders who have not registered their email address with the Registrar and Transfer Agent/Depository Participant(s).
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has announced its 41st Annual Report for the year 2025-26, along with the Notice of the Annual General Meeting (AGM) to be held on September 21, 2026. The report includes the audited standalone and consolidated financial statements for the year ended March 31, 2026.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has announced the 41st Annual General Meeting (AGM) to be held on September 21, 2026, through video conferencing. The meeting will consider the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and the reappointment of Kaushal Uttam Shah as Managing Director. Additionally, the meeting will consider approval for material related party transactions.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has announced a newspaper advertisement regarding its 41st Annual General Meeting (AGM) to be held on September 21, 2026, through video conference.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has approved a material related party transaction for the acquisition of the copyright and intellectual property portfolio of DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP for ₹10 Crores, funded from the company's rights issue proceeds.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has informed BSE that a Board Meeting is scheduled on 26/08/2026 to consider and approve a Related Party Transaction with Navahmedi Solution Private Limited for the acquisition of its business undertaking through a slump sale.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has shifted its registered office from Assam to Maharashtra, as approved by shareholders. A public notice was published in Times of India and Amar Asoom on August 21, 2026, inviting objections to the relocation.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has released the scrutinizer report for its postal ballot, which was held on August 13, 2026. The report shows that all six resolutions passed with unanimous approval from the public and promoter groups. The resolutions include the regularisation of Mr. Bidari Kotresh Anilkumar's appointment as Executive Director, the acquisition of Sushodha Institute of Gastroenterology Private Limited, and the preferential issue of equity shares for consideration other than cash.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has published its unaudited financial results for the 1st quarter ended June 30, 2026, in two newspapers, as approved by its Board of Directors on August 12, 2026.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has informed the exchange about the proposed incorporation of a wholly-owned subsidiary company in India, which will be engaged in insurance broking services.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has submitted its Annual Secretarial Compliance Report for the year ended 31st March 2026, as required by SEBI regulations.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has submitted a statement of deviation for the quarter ended 30 June 2026, stating that the deviation is not applicable under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Arvaya Healthcare Ltd
Arvaya Healthcare Ltd has announced unaudited financial results for the first quarter ended 30 June 2026, with the Board of Directors approving material related party transactions and appointments of Company Secretary and Independent Directors.